ACE inhibition salvages the visual loss caused by diabetes

Diabetologia

Volumn 46, Issue 3, 2003, Pages 401-408

  Bui, B V ^a   Armitage, J A ^a   Tolcos, M ^a   Cooper, M E ^a   Vingrys, A J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

ACE inhibition; ERG; Rats; Retina; Streptozotocin

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AMINOGUANIDINE; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; PERINDOPRIL; PROXYMETACAINE; STREPTOZOCIN; TROPICAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; DRUG MECHANISM; ELECTRORETINOGRAM; ENZYME INHIBITION; FLUID INTAKE; GLUCOSE BLOOD LEVEL; NONHUMAN; OSCILLATORY POTENTIAL; PHOTORECEPTOR; PHOTORECEPTOR POTENTIAL; PRIORITY JOURNAL; RAT; RAT STRAIN; RETINA DISEASE; URINE VOLUME; VISUAL IMPAIRMENT;

EID: 0038303104     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-003-1042-7     Document Type: Article

References (44)

1. Aiello LP, Gardner TW, King GL et al. (1998) Diabetic retinopathy. Diabetes Care 21:143-156
2. Mizutani M, Gerhardinger C, Lorenzi M (1998) Müller cell changes in human diabetic retinopathy. Diabetes 47:445-449
3. Lieth E, Gardner TW, Barber AJ, Antonetti DA (2000) Retinal neurodegeneration: early pathology in diabetes. Clin Experiment Ophthalmol 28:3-8
4. Coupland SG (1987) A comparison of oscillatory potential and pattern electroretinogram measures in diabetic retinopathy. Doc Ophthalmol 66:207-218
5. Juen S, Kieselbach GF (1990) Electrophysiological changes in juvenile diabetics without retinopathy. Arch Ophthalmol 108:372-375
6. Falsini B, Porciatti V, Scalia G et al. (1989) Steady-state pattern electroretinogram in insulin-dependent diabetics with no or minimal retinopathy. Doc Ophthalmol 73:193-200
7. Caputo S, Di Leo MA, Falsini B et al. (1990) Evidence for early impairment of macular function with pattern ERG in type I diabetic patients. Diabetes Care 13:412-418
8. Prager TC, Garcia CA, Mincher CA, Mishra J, Chu HH (1990) The pattern electroretinogram in diabetes. Am J Ophthalmol 109:279-284
9. Shirao Y, Kawasaki K (1998) Electrical responses from diabetic retina. Pro Ret Eye Res 17:59-76
10. Sakai H, Tani Y, Shirasawa E, Shirao Y, Kawasaki K (1995) Development of electroretinographic alterations in streptozotocin- induced diabetes in rats. Ophthalmic Res 27:57-63
11. Pautler EL, Ennis SR (1980) The effect of induced diabetes on the electroretinogram components of the pigmented rat. Invest Ophthalmol Vis Sci 19:702-705
12. Holopigian K, Greenstein VC, Seiple W, Hood DC, Carr RE (1997) Evidence for photoreceptor changes in patients with diabetic retinopathy. Invest Ophthalmol Vis Sci 38:2355-2365
13. Kurtenbach A, Wagner U, Neu A, Schiefer U, Ranke MB, Zrenner E (1994) Brightness matching and colour discrimination in young diabetics without retinopathy. Vision Res 34:115-122
14. Tregear SJ, Knowles PJ, Ripley LG, Casswell AG (1997) Chromatic-contrast threshold impairment in diabetes. Eye 11:537-546
15. Lieth E, Barber AJ, Xu B, Dice C, Ratz MJ, Tanase D, Strother JM (1998) Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn State Retina Research Group. Diabetes 47:815-820
16. Ottlecz A, Bensaoula T (1996) Captopril ameliorates the decreased Na+,K(+)-ATPase activity in the retina of streptozotocin-induced diabetic rats. Invest Ophthalmol Vis Sci 37:1633-1641
17. Chaturvedi N (2000) HOPE and extension of the indications for ACE inhibitors? Heart Outcomes Prevention Evaluation. Lancet 355:246-247
18. Nagisa Y, Shintani A, Nakagawa S (2001) The angiotensin II receptor antagonist candesartan cilexetil (TCV-116) ameliorates retinal disorders in rats. Diabetologia 44:883-888
19. Su EN, Alder VA, Yu DY, Yu PK, Cringle SJ, Yogesan K (2000) Continued progression of retinopathy despite spontaneous recovery to normoglycemia in a long-term study of streptozotocin-induced diabetes in rats. Graefes Arch Clin Exp Ophthalmol 238:163-173
20. Hood DC, Birch DG (1990) A quantitative measure of the electrical activity of human rod photoreceptors using electroretinography. Vis Neurosci 5:379-387
21. Hood DC, Birch DG (1992) A computational model of the amplitude and implicit time of the b-wave of the human ERG. Vis Neurosci 8:107-126
22. Bui BV, Armitage JA, Vingrys AJ (2002) Extraction and modelling of oscillatory potentials. Doc Ophthalmol 104:17-36
23. Lamb TD, Pugh EN Jr (1992) A quantitative account of the activation steps involved in phototransduction in amphibian photoreceptors. J Physiol (Lond) 449:719-758
24. Slaughter MM, Miller RF (1981) 2-amino-4-phosphonobutyric acid: a new pharmacological tool for retina research. Science 211:182-185
25. Nawy S, Jahr CE (1990) Suppression by glutamate of cGMP-activated conductance in retinal bipolar cells. Nature 346:269-271
26. Ames A 3rd, Li YY, Heher EC, Kimble CR (1992) Energy metabolism of rabbit retina as related to function: high cost of Na+ transport. J Neurosci 12:840-853
27. Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW (1998) Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest 102:783-791
28. Winkler BS (1983) Relative inhibitory effects of ATP depletion, ouabain and calcium on retinal photoreceptors. Exp Eye Res 36:581-594
29. Gerbi A, Maixent JM, Barbey O et al. (1998) Alterations of Na,K-ATPase isoenzymes in the rat diabetic neuropathy: protective effect of dietary supplementation with n-3 fatty acids. J Neurochem 71:732-740
30. Jacobi PC, Osswald H, Jurklies B, Zrenner E (1994) Neuromodulatory effects of the renin-angiotensin system on the cat electroretinogram. Invest Ophthalmol Vis Sci 35:973-980
31. Liu FY, Cogan MG (1990) Role of protein kinase C in proximal bicarbonate absorption and angiotensin signaling. Am J Physiol 258:F927-F933
32. Buhagiar KA, Hansen PS, Bewick NL, Rasmussen HH (2001) Protein kinase Cepsilon contributes to regulation of the sarcolemmal Na(+)-K(+) pump. Am J Physiol Cell Physiol 281:C1059-C1063
33. Shiba T, Inoguchi T, Sportsman JR, Heath WF, Bursell S, King GL (1993) Correlation of diacylglycerol level and protein kinase C activity in rat retina to retinal circulation. Am J Physiol 265:E783-E793
34. Ottlecz A, Bensaoula T, Eichberg J, Peterson RG (1996) Angiotensin-converting enzyme activity in retinas of streptozotocin- induced and Zucker diabetic rats. The effect of angiotensin II on Na+,K(+)-ATPase activity. Invest Ophthalmol Vis Sci 37:2157-2164
35. Cosenzi A, Bocin E, Sacerdote A et al. (1999) Antihypertensive drugs and the nervous system: ACE-inhibitors restore oscillatory potentials in hypertensives. Clin Exp Hypertens 21:223-231
36. Bensaoula T, Ottlecz A (2001) Biochemical and ultrastructural studies in the neural retina and retinal pigment epithelium of STZ-diabetic rats: effect of captopril. J Ocul Pharmacol Ther 17:573-586
37. Cooper ME, Bonnet F, Oldfield M, Jandeleit-Dahm K (2001) Mechanisms of diabetic vasculopathy: an overview. Am J Hypertens 14:475-486
38. Giardino I, Fard AK, Hatchell DL, Brownlee M (1998) Aminoguanidine inhibits reactive oxygen species formation, lipid peroxidation, and oxidant-induced apoptosis. Diabetes 47:1114-1120
39. Tilton RG, Chang K, Hasan et al. (1993) Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes 42:221-232
40. Du Y, Smith MA, Miller CM, Kern TS (2002) Diabetes-induced nitrative stress in the retina, and correction by aminoguanidine. J Neurochem 80:771-779
41. Neufeld AH, Sawada A, Becker B (1999) Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuro-protection of retinal ganglion cells in a rat model of chronic glaucoma. Proc Natl Acad Sci USA 96:9944-9948
42. Klein R (1995) Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 18:258-268
43. Hoogwerf B J, Young JB (2000) The HOPE study. Ramipril lowered cardiovascular risk, but vitamin E did not. Cleve Clin J Med 67:287-293
44. Chaturvedi N, Sjolie AK, Stephenson JM et al. (1998) Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus. Lancet 351:28-31